GlassScriptPhysician profile
Martin S Weiss
NPI 1255396263
$9,683.92
in general payments reported to CMS, 2019-2025
49 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,200 · 2020: $744 · 2021: $745 · 2022: $1,980 · 2023: $1,420 · 2024: $1,446 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,015.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,918.65 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $1,081.94 | 2023-2025 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $616.81 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $600.41 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $522.24 | 2021-2025 | Verquvo |
| Amgen INC. | $485.79 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $458.72 | 2019-2024 | |
| Itamar Medical INC | $381.92 | 2021-2023 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.24 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $244.22 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $191.03 | 2019-2024 | |
| Medtronic, INC. | $168.62 | 2023 | Onyx Frontier |
| Abbott Laboratories | $164.68 | 2019-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Heartflow, INC. | $162.43 | 2019-2022 | |
| Novo Nordisk INC | $151.50 | 2021-2025 | Wegovy, Ozempic |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $139.89 | 2024 | Sapien 3 Ultra Resilia |
| Cvrx, INC. | $133.89 | 2024-2025 | Barostim Neo System |
| Atricure, INC. | $130.73 | 2022 | |
| Astellas Pharma US INC | $128.33 | 2019 | |
| Philips North America LLC | $127.55 | 2019-2025 | Extended Holter |
| Getinge USA Sales, LLC | $121.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $120.84 | 2019-2021 | |
| Esperion Therapeutics, INC. | $117.99 | 2021-2025 | Nexletol |
| Shockwave Medical, INC | $106.83 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Tactile Systems Technology INC | $100.34 | 2023 | Flexitouch Plus, Entre Plus |
| Astrazeneca Pharmaceuticals LP | $92.24 | 2019-2023 | Farxiga |
| Scpharmaceuticals INC. | $85.00 | 2023-2025 | |
| Medtronic Vascular, INC. | $70.57 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $69.52 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $64.91 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals, LTD. | $62.35 | 2021-2023 | Arcalyst |
| Amarin Pharma, INC. | $58.01 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.63 | 2025 | |
| Abiomed | $38.42 | 2025 | |
| Bardy Diagnostics, INC. | $35.56 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $33.07 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $32.14 | 2019 | |
| Medicomp INC | $30.70 | 2024 | Telepatch Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $30.60 | 2025 | Amvuttra |
| Lantheus Medical Imaging, INC. | $29.14 | 2019 | |
| Kestra Medical Technology Services, INC. | $27.11 | 2025 | Assure Wcd |
| Biotronik INC. | $23.45 | 2019 | |
| Glaxosmithkline, LLC. | $20.01 | 2025 | Shingrix, Arexvy |
| Innovation Technologies INC | $19.84 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.83 | 2019 | |
| Angiodynamics, INC. | $14.78 | 2021 | |
| Hitachi Healthcare Americas Corp. | $11.15 | 2019 | |
| Althera Pharmaceuticals LLC | $9.92 | 2022 | |
| Elutia, INC. | $9.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.